APBB1IP

Across TCGA pan-cancer cohorts, APBB1IP mass-spec protein differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of APBB1IP’s most consistent transcriptional readouts.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where APBB1IP mass-spec protein is more highly expressed in tumor relative to normal tissue. In most cancer types APBB1IP is over-expressed in tumor, although a few such as LSCC and COAD show the opposite, repressed pattern.

CCRCC, PDAC, and LSCC are the cancer types where APBB1IP tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in APBB1IP mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
CCRCC	Female	All	+1.433	<.001	12	view →
PDAC	Female	All	+0.662	<.001	4	view →
LSCC	Male	II,III,IV	−0.261	<.001	4	view →
HNSC	All	All	+0.204	.001	4	view →
COAD	All	III,IV	−0.175	.032	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

APBB1IP–CCRCC

Open the CCRCC breakdown →